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Abstract
The majority of proteases are synthesized in an inactive form, termed zymogen, which consists of a propeptide and a
protease domain. The propeptide is commonly involved in the correct folding and specific inhibition of the enzyme. The
propeptide of the house dust mite allergen Der p 3, NPILPASPNAT, contains a proline-rich motif (PRM), which is unusual for
a trypsin-like protease. By truncating the propeptide or replacing one or all of the prolines in the non-glycosylated zymogen
with alanine(s), we demonstrated that the full-length propeptide is not required for correct folding and thermal stability and
that the PRM is important for the resistance of proDer p 3 to undesired proteolysis when the protein is expressed in Pichia
pastoris. Additionally, we followed the maturation time course of proDer p 3 by coupling a quenched-flow assay to mass
spectrometry analysis. This approach allowed to monitor the evolution of the different species and to determine the steady-
state kinetic parameters for activation of the zymogen by the major allergen Der p 1. This experiment demonstrated that
prolines 5 and 8 are crucial for proDer p 3-Der p 1 interaction and for activation of the zymogen.
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Introduction
Proteases control diverse processes including digestion, blood
coagulation, immune reactions and apoptosis and are essential
physiological factors [1]. However, their activities can be
hazardous if uncontrolled [2]. Accordingly, studies describing
the implication of endogenous or exogenous proteases in
pathological processes such as Alzheimer’s disease, cancer,
malaria, AIDS and asthma have increased in recent years
[3,4,5,6,7,8]. Understanding the regulation of proteolytic activity
is of great interest, particularly for the design and synthesis of new
therapeutic molecules [2,7].
For patients suffering from allergy (20–30% of the worldwide
population), sensitization to house dust mite (HDM) allergens is a
high risk factor for the development of asthma [9,10]. Allergen
groups 1, 3, 6 and 9 from Dermatophagoides pteronyssinus (D.
pteronyssinus) and D. farinae, which contain cysteine (group 1,
papaı¨n-like) and serine (group 3 trypsin, group 6 chymotrypsin and
group 9 elastase-like) proteases, have been shown to be involved in
the development and chronicity of allergy [11]. Indeed, these
allergens induce IgE synthesis in allergic patients, and their
proteolytic activity is involved in the targeting of epithelial cells
and cells of the innate and adaptive immune systems [12]. These
allergens can promote allergen penetration, IgE hyper-production
and enhancement of the inflammatory process [13,14,15,16].
Mites synthesize proteases as zymogens, which consist of an N-
terminal propeptide of 6 to 82 amino acids and a protease domain
of 220 to 232 residues corresponding to the active enzyme [11].
The most common function of propeptides is to inhibit the
protease so that the enzyme-producing tissues are protected
against non-specific degradation. After synthesis as an inactive
zymogen, the propeptide is cleaved at precise times and locations
by a specific intra- or inter-molecular process [2]. In the serine and
cysteine protease families, the propeptide can also act as an intra-
molecular chaperone, assisting with correct folding. Without this
sequence, the enzyme remains blocked in a transitory inactive
(molten globule) state, indicating that the propeptide is necessary
for the late stage leading to the correctly folded proenzyme [17].
This process has been described in detail, including for a-lytic
protease and subtilisin [18,19,20]. Recombinant expression of Der
p 1 and Der p 3 in the absence of the propeptide sequence in
Escherichia coli or Saccharomyces cerevisiae leads to incorrectly folded
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proteins with reduced IgE-binding reactivity, suggesting that the
propeptides also act as intra-molecular chaperones [21,22,23,24].
Most studies have focused on the role of the D. pteronyssinus major
allergen Der p 1. However, our previous work demonstrated that
Der p 3 exhibits a 50-fold higher catalytic efficiency and a less
marked specificity than Der p 1 for residues in the P2 and P3
positions of substrates (Schechter and Berger’s nomenclature [25])
[26,27]. As a consequence, the list of known Der p 3 substrates
involved in allergy (e.g., transmembrane protein junctions, the
PAR-2 receptor of the lung epithelial cells and complement
proteins C3 and C5) is likely not exhaustive [28,29,30].
Compared with other trypsin-like proteases, the propeptide of
proDer p 3 has some distinct features. First, the absence of Lys or
Arg in the P1 position results in inter-molecular activation
mediated by Der p 1 [26]. Second, the 11-amino-acid propeptide
of proDer p 3 contains 3 prolines that form a PxxPxxP motif
(NP2ILP5ASP8NAT11). Such proline-rich motifs (PRMs) are
known to induce conformational constraints that can protect
peptides against non-specific proteolytic degradation [31]. Inter-
estingly, PxxP motifs adopt a very stable structure, i.e., a left-
handed polyproline II (PPII) helix with three residues per turn in
which the side chains are exposed on the surface of the helix. This
arrangement provides an accessible interface for specific protein-
protein interactions with little loss of entropy upon binding due to
the rigidity of the structure [32,33]. Therefore, the role of the
proDer p 3 propeptide and, more specifically, of its PRM in the
correct folding of the protein, in its activation mechanism and in
the stability of the zymogen is of interest.
In this study, we report the involvement of the proDer p 3
propeptide in the formation of a correctly processed protein.
Using quenched-flow coupled to mass spectrometry, we
followed in real time the Der p 1-mediated activation of proDer
p 3 mutants in which proline(s) were replaced by alanine(s). We
demonstrated the crucial role played by the PRM and, in
particular, of prolines 5 and 8 in the inter-molecular activation
mechanism of proDer p 3.
Materials and Methods
Chemicals
Boc-IEGR-Methoxycoumarin acetate (MCA) and the cysteine
protease inhibitor L-trans-epoxysuccinyl-leucylamido (4-guani-
dino) butane (E-64) were purchased from Bachem (Buttendorf,
Switzerland). Unglycosylated recombinant mature Der p 1 was
obtained from Pichia pastoris proDer p 1 as previously described
[34]. Leucine enkephalin acetate salt hydrate was purchased from
Sigma Aldrich (Saint-Louis, Missouri, USA).
Expression of recombinant proDer p 3 zymogens in
Pichia pastoris
The proDer p 3 mutants containing a single proline to alanine
mutation are referred to as P2A, P5A and P8A. The zymogen in
which all prolines are mutated to alanines is denoted as P-A. The
proDer p 3 zymogens in which the 2, 5, 8 or 11 N-terminal amino
acids are deleted are referred to as D1–2, D1–5, D1–8 or D1–11,
respectively. All zymogens were constructed by PCR in which the
Pichia codon-optimized N9Q proDer p 3 sequence was used as the
template and primers introducing EcoR I and Xba I restriction sites
were used, as previously described [26]. In these constructions, the
N-glycosylation site in the propeptide (N9) was eliminated by
substitution of asparagine by glutamine (N9Q). Briefly, after
cloning into the pGEM-T Easy vector (Promega, Madison, USA)
and DNA sequencing, proDer p 3 sequences were cloned into the
pPICZaA vector downstream of the peptide signal of Saccharomyces
cerevisiae factor a (Invitrogen, Groeningen, The Netherlands). After
electroporation of the P. pastoris SMD1168 strain with the
recombinant plasmids, transformants were selected on yeast
extract peptone dextrose (YPD) medium containing zeocine
(50 mg/ml) (Invitrogen). Expression of the zymogens (five clones
per protein) was then tested by culturing in 100 ml buffered media
with glycerol for yeast (BMGY) at 28uC until an A600 value of
approximately 1 was reached. The cultures were centrifuged for
10 min at 5000 g. The pellets were resuspended in 100 ml
buffered methanol-complex medium for yeast (BMMY, 0.5%
methanol) for expression at 28uC for three days. The cultures were
centrifuged at 10000 g for 10 min, and the supernatant was stored
at 220uC. For each zymogen, the best producer was chosen after
SDS-PAGE analysis, and expression of the proteins was performed
for 48 hours in flasks (total volume of 1 L). The cultures were then
centrifuged at 13000 g for 20 min, and supernatants containing
the secreted proteins were stored at 220uC.
Purification of recombinant proDer p 3 zymogens and
Der p 3
Zymogens were purified from the supernatants of 1-L cultures
as previously described [26] with slight modifications. Briefly,
proteins were first purified by ion exchange chromatography with
a Q Streamline exchanger (Amersham Biosciences, GE Health-
care, Uppsala, Sweden) and then a Q-HP Sepharose column
(60 ml) (2.6610 cm, Amersham Biosciences, GE Healthcare,
Uppsala, Sweden). To completely eliminate the pigments present
in the culture media, the flow-through fraction containing the
zymogens was dialyzed at 4uC against 20 mM sodium acetate,
pH 5.5 (buffer A), before purification on a CM-HP Sepharose
column (25 ml) (1.6610 cm, Amersham Biosciences, GE Health-
care, Uppsala, Sweden) equilibrated with buffer A. Bound proteins
were progressively eluted with a linear gradient of buffer A
containing 1 M NaCl over 10 column volumes. After SDS-PAGE
analysis, fractions containing zymogens were pooled, dialyzed at
4uC against 20 mM ethanolamine/HCl, pH 9, and stored at
220uC. The concentration of zymogens was estimated by the
BCA assay (Pierce, Rockford, USA).
After activation of 3 mM proDer p 3 by different concentrations
of Der p 1 (20 nM for proDer p 3 and D1–2, 40 nM for proDer p
3 D1–5 and 340 nM for proDer p 3 D1–8) at 37uC for 90 min, the
reaction was stopped by addition of 100 mM E-64. For each
activation, mature Der p 3 was isolated by a fourth purification
step on a 1-ml MonoQ column (0.565 cm, Amersham Bioscienc-
es, GE Healthcare, Uppsala, Sweden) equilibrated with 20 mM
Tris-HCl, pH 8.5 (buffer B). Elution was performed with a linear
gradient of buffer B containing 1 M NaCl over 10 column
volumes. Fractions containing the Der p 3 activity were pooled
and dialyzed against 20 mM ethanolamine/HCl, pH 9, before
storage at 220uC.
Fluorescence measurements
The intrinsic fluorescence of the purified proteins (4 mM) was
recorded at 25uC in 20 mM ethanolamine/HCl, pH 9, on a
Varian Cary Eclipse spectrofluorimeter using a scan rate of
350 nm min21. The excitation and emission slit widths were 10
and 5 nm, respectively. The excitation wavelength was 280 nm,
and emission spectra were recorded from 300 nm to 400 nm. The
spectra were measured five times and averaged, and the
fluorescence background of the buffer was subtracted.
For the heat-induced unfolding experiments, the temperature
was increased from 20uC to 70uC at a rate of 0.5uC min21. The
fluorescence emission was monitored at 320 nm every 30 s. The
transition curves were computed based on the assumption of a
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two-state model and analyzed according to the following equation
[35]:
yobs~
(yNzpT)z(yUzqT)|exp(a)
1zexp(a)
ð1Þ
where: a~{
(DHm(1{T=Tm))
RT
; yobs is the observed F signal at
320 nm at a given temperature; yN and yU represent the values of
yobs for the native and denatured states, respectively; p and q are
the slopes of the pre- and post-transition baselines, respectively; R
is the gas constant; T is the absolute temperature; Tm is the
temperature of the mid-transition; and DHm is the enthalpy value
at Tm. Because the transitions were irreversible, we considered
only the (apparent) Tm value.
N-terminal sequencing
The proteins were sequenced on an Applied Biosystems 476A
protein sequencer (Applied Biosystems) using Edman degradation
as previously described [26].
Activation of proDer p 3 zymogens by Der p 1
The proDer p 3 zymogens (2.5 mM) were incubated at 37uC for
various lengths of time with Der p 1 (30 nM) in PBS, pH 7.4,
containing 5 mM DTT and 5 mM EDTA. Samples were
analyzed by SDS-PAGE, and Der p 3 activity was determined.
The samples were diluted 2000-fold in 50 mM polybuffer 1,
pH 8.5 (mixture of 50 mM Tris, citrate, CAPS and potassium
chloride) and the hydrolysis of 150 mM Boc-IEGR-MCA was
monitored for 180 s at 37uC in a Perkin-Elmer LS 50 B
instrument with excitation and emission wavelengths of 380 and
460 nm, respectively.
The activities of mature Der p 3 (200 nM) from activated
proDer p 3 and from the activated D1–2, D1–5 and D1–8 proteins
were monitored as described above and determined with the use of
an MCA (Sigma, Saint-Louis, Missouri, USA) standard curve with
concentrations ranging from 0 to 1.8 mM.
Activation kinetics of proDer p 3 and P2A, P5A, P8A and
P-A mutants
ProDer p 3 zymogens (12.5 nM) were activated at 37uC in the
presence of increasing concentrations of Der p 1 (0–1.5 nM) in
50 mM polybuffer 2 (mixture of 50 mM Tris, phosphate, citrate,
acetate and KCl containing 1 mM DTT and 1 mM EDTA,
adjusted to pH 7.4). The Der p 3 enzymatic activity was
monitored continuously by measuring the hydrolysis of 10 mM
Boc-IEGR-MCA for 30 min.
Data were fitted to equation 2 and, the pseudo first-order rate
constants (kobs) were plotted as a function of the Der p 1
concentration as previously described [26].
P~vsstz
vss{v0
kobs
e(({kobst){1) ð2Þ
where P, v0, vss correspond respectively to the amount of MCA
produced (mM), the initial rate for product release (mM/s) and the
steady-state rate for product release (mM/s).
Activation of proDer p 3 monitored by quenched-flow
electrospray mass spectrometry
The proteins were desalted in 25 mM ammonium acetate,
pH 7.4, with a Microcon system. In these experiments, the
activating mixtures contained 16 mM proDer p 3 zymogens,
0.16 mM Der p 1 and 1.8 mM leucine enkephalin (internal
standard) in 25 mM ammonium acetate, pH 7.4, with 1 mM
DTT. The quenching solvent was an aqueous solution of 20%
methanol and 0.8% acetic acid. These two solutions were
continuously introduced via two independent syringe pumps in a
mixing chamber at a 3 ml min21 flow rate and injected into a Q-
ToF Ultima Global electrospray mass spectrometer (Waters,
Manchester, U.K.). The electrospray source was operated in
positive ion mode (capillary voltage of 3 kV). Mass spectra were
recorded with a speed of 20 min21 and analyzed with MassLynx
4.1 software. An extracted ion current for each species (intensity
vs. time) was reconstructed for quantification. The extracted
intensities of the different charge states of a protein (m/z) were
normalized with the intensity of the internal standard (leucine
enkephalin) over time according to equation 3.
It~
Io
Istd
ð3Þ
where It, Io and Istd correspond to the normalized peak intensity of
a defined charge state at time t, the peak intensity observed for this
charge state and the peak intensity of the internal standard,
respectively.
The normalized intensities corresponding to the different
charged states of a protein were summed and the relative
concentrations of the different proteins over time were then
calculated according to equation 4.
Ct~
C0
I0
|
X
I
 
ð4Þ
where Ct, C0, I0 and SI correspond respectively to the amount of
protein at time t (mM), the initial concentration of zymogen
(16 mM), the initial normalized peak intensity of zymogen and the
sum of the normalized peak intensities of the different charge states
of the protein to be considered, respectively.
For the P2A, P5A, P8A and P-A mutants, which exhibited
truncated zymogen forms at the beginning of the reaction, I0
corresponded to the sum of the initial normalized peak intensities
of these species.
Nucleotide sequence accession number
The nucleotide sequence data encoding for N9Q proDer p 3,
N9QS196A proDer p 3, P2A, P2AS196A, P5A, P5AS196A, P8A,
P8AS196A, P-A, P-AS196A, D1–2, D1–2S196A, D1–5, D1–
5S196A, D1–8, D1–8S196A, D1–11 and D1–11S196A have been
deposited in the GenBank database under accession numbers
KC879084, KC879085, KC879086, KC879087, KC879088,
KC879089, KC879090, KC879091, KC879092, KC879093,
KC879094, KC879095, KC879096, KC879097, KC879098,
KC879099, KC8790100 and KC8790101, respectively.
Results
Role of the proDer p 3 propeptide in the production of a
correctly processed protein
In our previous study, we showed that proDer p 3 expressed in
P. pastoris is hyperglycosylated at the N9AT site of the propeptide.
The use of the N9Q proDer p 3 mutant evidenced that
glycoslylation is neither involved in the correct folding of the
zymogen nor in inhibition of its enzymatic activity. However,
glycosylation was very heterogeneous and it has been shown to
decrease the zymogen activation rate [26]. To be independent of
such a glycosylation regulation, all proteins expressed in this study
Role of the Prolines of Der p 3 Propeptide
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contained the N9Q mutation. For all experiments, the N9Q
proDer p 3 mutant was used as reference and termed proDer p 3.
To explore the role of the propeptide and, more specifically, of
its proline residues in the recombinant expression, stability and
activation of the proDer p 3 zymogen, the P2A, P5A, P8A and P-A
mutants in which proline(s) are replaced by alanine(s) and the D1–
2, D1–5, D1–8 and D1–11 proteins in which 2, 5, 8 and 11
residues of the propeptide are deleted were constructed and
expressed in P. pastoris (Table 1). All proteins were secreted into the
culture medium and purified to homogeneity from culture
supernatants (1 L) to obtain between 6 and 15 mg of protein.
For all zymogens, two additional residues (EF21-) resulting from
the Eco RI cloning site of the pPICZaA plasmid were observed as
previously described (Table 1 and Table S1) [26].
The N-terminal sequences of proDer p 3 and of the P2A, D1–2,
P5A and D1–5 zymogens were as expected despite the presence of
small amounts (max 8%) of N-truncated forms (Table 1). By
contrast, the P8A and P-A mutants were largely truncated in the
propeptide and the protease domain, indicating a role for the
prolines, especially proline 8, in resistance to non-specific
degradation (Table S1). To reduce degradation, all proteins were
purified at 4uC. Although the P-A mutant still exhibited truncation
(Table 1), 94% corresponded to zymogen forms that could be
activated by the Der p 1 protease.
The D1–11 protein, in which the complete propeptide of
proDer p 3 is deleted and corresponds to ‘‘mature Der p 3’’,
presented two (EAEF21-) or four additional residues (EAEAEF21-)
compared to other zymogens (Table 1). These residues arise from
incomplete processing of the a-factor of the yeast Saccharomyces
cerevisiae leader sequence, which is upstream of the proDer p 3
sequence in the pPICZa plasmid.
Role of the proDer p 3 propeptide in the acquisition of
the tridimensional structure of the zymogen
All proline mutants and deleted forms (four tryptophan residues)
displayed intrinsic fluorescence spectra similar to that obtained for
Table 1. N-terminal sequences of proDer p 3 zymogens obtained after purification at 4uC.
Proteins Expected and observed N-terminal sequences Approximate (%)
proDer p 3 NPILPASPQATIVGGEKALAG…
4uC EFNPILPASPQATIVGGEKALAG 100
P2A proDer p 3 NAILPASPQATIVGGEKALAG…
4uC EFNAILPASPQATIVGGEKALAG 100
P5A proDer p 3 NPILAASPQATIVGGEKALAG…
4uC EFNPILAASPQATIVGGEKALAG 100
P8A proDer p 3 NPILPASAQATIVGGEKALAG…
4uC EFNPILPASAQATIVGGEKALAG 100
P-A proDer p 3 NAILAASAQATIVGGEKALAG…
4uC EFNAILAASAQATIVGGEKALAG 8
ILAASAQATIVGGEKALAG 5
ASAQATIVGGEKALAG 9
SAQATIVGGEKALAG 42
AQATIVGGEKALAG 16
ATIVGGEKALAG 14
ALAGE 6
D1–2 proDer p 3 ILPASPQATIVGGEKALAG…
4uC EFILPASPQATIVGGEKALAG 88
SPQATIVGGEKALAG 3
Not identified 9
D1–5 proDer p 3 ASPQATIVGGEKALAG…
4uC EFASPQATIVGGEKALAG 88
ATIVGGEKALAG 8
Not identified 4
D1–8 proDer p 3 QATIVGGEKALAG…
4uC EFQATIVGGEKALAG 24
EAEFQATIVGGEKALAG 74
Not identified 2
D1–11 proDer p 3 IVGGEKALAG…
4uC EAEFIVGGEKALAG 94
EAEAEFIVGGEKALAG 6
All proteins contain the N9Q mutation, which abolishes N-glycosylation of the propeptide. The mature Der p 3 sequence is shown in italics. The EF N-terminal extension
resulted from cloning.
doi:10.1371/journal.pone.0068014.t001
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proDer p 3, with an emission maximum wavelength approxi-
mately 333 nm. This result indicates that all of the zymogens
adopt the same global fold. The spectra of proDer p 3, P-A and
D1–11 are shown in Fig. 1.
Following maturation of proDer p 3 by Der p 1, mature Der p 3
exhibited a red shift of the maximum emission wavelength to
350 nm. Interestingly, although the D1–11 protein does not
contain the propeptide sequence, its fluorescence properties are
‘‘zymogen-like’’.
The specific activities of the zymogens expressed in P. pastoris
were measured with the Boc-IEGR-MCA substrate [26]. The
activities were similar and ranged from 0.2 to 3% of the mature
Der p 3 activity, although the activity of the D1–11 protein was
only 0.01% (Table 2). A time-course SDS-PAGE analysis of the
proDer p 3 mutants (3.9 mM) incubated at 37uC in 20 mM
ethanolamine/HCl, pH 9, indicated that the P8A and P-A
proteins were completely degraded within 24 to 48 hours instead
of 48 to 96 hours for proDer p 3 and for the P2A and P5A
mutants (data not shown).These results could be related to the
slightly higher activity measured for P8A and P-A mutants
(Table 2).
Role of the proDer p 3 propeptide in the thermal stability
of the protein
Heat-induced denaturation (Fig. 2) was found to be irreversible.
The transition curves obtained with all zymogens were similar and
characteristic of a one-step unfolding mechanism. As shown in
Table 3, the apparent mid-point values for the thermal unfolding
of proDer p 3 and the proline mutants are similar but are slightly
lower for the P8A and P-A zymogens, which is probably due to the
higher proteolytic activity exhibited by these mutants.
To test this hypothesis, the corresponding S196A mutants, in
which the active serine (S196) is replaced by an alanine were
studied (Fig. 2). All mutants exhibited the same intrinsic
fluorescence spectra than their corresponding active forms (data
not shown). The inactive mutants displayed a 5uC increase in their
apparent Tm values, indicating that the enzymatic activity
influences the stability of the proteins. Similar apparent Tm values
(54–55uC, data not shown) were found with all the S196A proline
mutants and the S196A deleted forms, indicating that the prolines
of the propeptide should not be involved in the intrinsic thermal
stability of the zymogen.
Importance of the prolines in the propeptide of proDer p
3 for recognition by Der p 1
As shown by SDS-PAGE analysis, the incubation of proDer p 3
in the presence of Der p 1 resulted in the total disappearance of
the zymogen after 9 min (Fig. 3A). This maturation corresponds to
the loss of the entire proDer p 3 propeptide in a one-step
mechanism that is correlated with the increase in Der p 3 protease
activity (Fig. 3D) [26]. After longer periods of time, the observed
decrease in Der p 3 activity may be due to auto-hydrolysis at the
NAK115 cleavage site of the enzyme, which is commonly observed
in trypsin-like proteases [26,36].
While activation of the P2A and D1–2 proteins yielded identical
SDS-PAGE results (data not shown) and activity (Fig. 3D) profiles
as those of proDer p 3, the P5A and D1–5 proteins displayed
intermediate behaviors (Fig. 3B and 3D) with a maximum after
18 min that was only 25% of the expected activity.
The activation rates of the P8A, D1–8 and P-A proteins were
drastically decreased. Indeed, the measured maximum Der p 3
Figure 1. Intrinsic fluorescence emission spectra. Intrinsic
fluorescence emission spectra of proDer p 3 (black), P-A (light gray),
D1–11 (dark gray) and Der p 3 (dotted black-gray) in 20 mM
ethanolamine/HCl, pH 9, at 25uC. A protein concentration of 4 mM
and an excitation wavelength of 280 nm were used.
doi:10.1371/journal.pone.0068014.g001
Table 2. kcat values of 12.5 nM proDer p 3 zymogens
determined with the use of 150 mM IEGR-MCA in 50 M
polybuffer 1 at 37uC.
Zymogen kcat (min
21)
proDer p 3 1061
P2A proDer p 3 1160
P5A proDer p 3 560
P8A proDer p 3 4063
P-A proDer p 3 10363
D1–8 proDer p 3 2363
D1–11 proDer p 3 0.2560.03
Der p 3 32006100
doi:10.1371/journal.pone.0068014.t002
Figure 2. Heat-induced unfolding transitions monitored by
fluorescence emission at 320 nm. The fractions of unfolded proDer
p 3 wild type and mutants as a function of temperature.
doi:10.1371/journal.pone.0068014.g002
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activity was only approximately 5% proDer p 3 activation
(Fig. 3D), and the appearance of mature Der p 3 was not
observed by SDS-PAGE analysis (Fig. 3C). After the P8A and P-A
mutants were incubated with Der p 1 for 6 hours, a truncated and
inactive form of Der p 3 with an A18LAG- N-terminal sequence
was observed.
To increase the maturation rates, the zymogens were incubated
with higher concentrations of Der p 1 for 30 min (Fig. 4), and Der
p 3 activity was continuously monitored. In the absence of Der p 1,
the activities of the zymogens were maintained constant with time,
indicating that they cannot auto-activate themselves. Accordingly,
a lack of auto-activation has been described for proDer p 3 [26].
However, the P8A and P-A proteins displayed higher basal
enzymatic activities (Fig. 4C), which could be related to the N-
terminal truncations of these mutants. The pseudo first-order rate
constants, kobs (Table 4) obtained according to equation 2, for the
maturation kinetics of proDer p 3 and P2A by 1 nM Der p 1 were
similar (Fig. 4A), whereas the activation rate of the P5A protein
was lower (Fig. 4B). Moreover, at this activating concentration, the
enzymatic activities of the P8A and P-A mutants were constant,
indicating that they did not mature during the experimental
timeframe. However, the slightly higher basal enzymatic activity
detected in the presence of 1 nM Der p 1 remains unexplained
(Fig. 4C). These results indicate that proline 8 and, to a lesser
extent, proline 5 are essential for activation by Der p 1.
The use of Der p 1 at higher concentrations (23 and 232 nM)
for the P5A (Fig. 4B) and P8A and P-A mutants (Fig. 4C),
respectively, allowed the activation of the zymogens. Despite the
high concentrations of Der p 1 needed to achieve these
maturations, the neo-formed Der p 3 displayed an activity similar
to that obtained upon maturation of proDer p 3.
Finally, proDer p 3 and the D1–2, D1–5 and D1–8 deleted
proteins were totally activated by different concentrations of Der p
1 for 90 min. After total activation (as confirmed by SDS-PAGE),
the corresponding active forms of the various zymogens were
purified, and their specific activities were determined. The
activities of the mature forms were similar (data not shown),
confirming that they adopt the correct fold.
Insights into the activation pathway of proDer p 3
The maturation of proDer p 3 and the proline mutants by Der p
1 was continuously monitored with a quenched-flow system
coupled to a Q-ToF electrospray mass spectrometer. After
desalting the proteins, proDer p 3 and Der p 1 were mixed in
the presence of leucine enkephalin as an internal standard and
mixed at a constant flow rate of 3 ml min21 with co-solvent
injected at the same rate. The mixture was continuously injected
into the spectrometer, and mass spectra were recorded every 3 s
during the maturation.
For the proDer p 3 activation, at the beginning of the reaction,
ions with m/z values of 2197, 2397 and 2636, corresponding to
[proDer p 3, mass: 26354 Da]12+, [proDer p 3]11+ and [proDer p
3]10+, respectively, were observed (Fig. 5A). These species
decreased with time, whereas ions showing m/z values of 2083,
2273, 2500 and 2778, corresponding to [Der p 3, mass: 24987
Da]12+, [Der p 3]11+, [Der p 3]10+ and [Der p 3]9+, respectively,
appeared together with the proDer p 3 propeptide (1385 Da)
(Fig. 5B). In addition, low amounts of small unidentified fragments
resulting from the non-specific hydrolysis of Der p 3 were also
observed. For each ion, the peak intensity as a function of time was
normalized against the peak intensity of the internal standard
(leucine enkephalin, mass: 556 Da). The relative intensities of the
different ions coming from one protein were summed, and the
relative concentrations were calculated and are reported as a
function of the activation time. Analysis of the kinetics shown in
Figure 5C permitted the determination of an approximate
Michaelis-Menten constant (Km) of Der p 1 for proDer p 3 of 3
to 6 mM and a specificity constant (kcat/Km) of 22 to
44 mM21 s21.
Spontaneous hydrolysis of all proline mutants occurred upon
desalting. Mass spectrometry permitted to independently monitor
the different truncated forms during the activation process of
proDer p 3 by Der p 1. For the P2A mutant, the entire zymogen
and its truncated AILPASPQAT- form were activated whereas the
SPQAT- form was unchanged (Fig. 6A). The intact form of P5A
(EFNPILAASPQAT-) and its three truncated forms AASPQAT-,
ASPQAT- and SPQAT- were processed into the native protein
Der p 3 (IVGG-) (Fig. 6B). The processing rate was higher for the
intact form. The QAT- and AT- forms were not processed at all.
For the P8A mutant, the intact form disappeared; however, the
processing yielded the truncated and inactive AT-, QAT- and
SAQAT- forms rather than the native protein Der p 3 (Fig. 6C).
Strikingly, and in contrast to the SPQAT form of the P5A mutant,
the SAQAT form of the P8A protein was not further processed,
which confirmed the importance of proline 8 in the activation
reaction. For the P-A mutant, there was no intact zymogen at the
beginning of the reaction, and the SAQAT-, AQAT- and AT-
forms were not processed into Der p 3 (Fig. 6D). Notably, the
proportions of active enzyme obtained for each zymogen
maturation (Fig. 6) roughly correspond to those described in
Fig. 3D.
Discussion
When compared to other trypsin-like proteases, the Der p 3
propeptide exhibits some interesting and distinct features. In our
previous study, we demonstrated that the absence of a DDDDK
motif and the presence of a threonine at the C-terminus of the
propeptide results in an unusual activation mechanism mediated
by Der p 1 [26]. N-glycosylation at the N9AT- position, near the
proDer p 3 cleavage site, decreases the maturation rate, as shown
for Der p 1 [37]. The propeptide of Der p 3 also contains a
PxxPxxP motif (NP2ILP5ASP8NAT11); the involvement of this
motif in folding and activation by Der p 1 is the focus of the
present study. To explore the role of these prolines, P2A, P5A,
P8A and P-A mutants as well as the D1–2, D1–5, D1–8 and D1–11
proteins were constructed.
P. pastoris was used to produce all of the proteins as secreted
forms. Examination of the purified preparations by N-terminal
sequencing and electrospray mass spectrometry revealed the
presence of different N-truncated forms for the P5A, P8A and
Table 3. Apparent Tm values of the different proDer p 3
zymogens.
Zymogen Tm (6C)
proDer p 3 49.560.1
P2A proDer p 3 49.160.1
P5A proDer p 3 49.460.1
P8A proDer p 3 48.760.1
P-A proDer p 3 48.160.1
S196A proDer p 3 54.260.1
P-AS196A proDer p 3 55.160.4
doi:10.1371/journal.pone.0068014.t003
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Figure 3. Inter-molecular activation of proDer p 3 zymogens by Der p 1. A: proDer p 3, B: P5A mutant and C: P8A mutant. SDS-PAGE (15%)
analysis: 2.5 mM proDer p 3, P5A or P8A (lanes I) was incubated at 37uC in 50 mM PBS, pH 7.4, containing 5 mM DTT and 5 mM EDTA with 30 nM Der
p 1. Lanes II: 2.2 mM Der p 1 as reference. The protein molecular mass marker (St) was from Fermentas. D: Der p 3 activities corresponding to the
activations of (green) proDer p 3, (yellow) P2A, (red) D1–2, (pink) P5A, (blue) D1–5, (gray) P8A, (cyan) D1–8 or (dark red) P-A by 30 nM Der p 1 for
increasing times of 0 to 24 min. Proteins were diluted 2000-fold, and Der p 3 activity was measured using IEGR-MCA as the substrate (150 mM).
doi:10.1371/journal.pone.0068014.g003
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P-A zymogens. Indeed, proline conformational constraints are
known to induce structural resistance to non-specific degradations
of the N-terminal X-proline sequences of several biological
peptides, such as cytokines or growth factors [31]. Therefore,
the prolines of the proDer p 3 prosequence are likely involved in
the protection of the zymogen against undesired hydrolysis.
The presence of the additional residues EA and EAEA at the N-
terminus of the D1–11 protein indicates that during its secretion in
P. pastoris, the a-factor signal peptide is not completely cleaved by
the dipeptidyl aminopeptidase. This result suggests that the
presence of proDer p 3 propeptide is also important for correct
processing (i.e., elimination of the yeast signal peptide) of the
zymogen during its secretion. In this case, the propeptide could be
considered as a spacer situated between the signal peptide cleavage
site and the core of the protein, promoting its correct processing.
Although proDer p 3 propeptide is involved in the production of
a correctly processed protein and in the resistance to undesired
proteolysis, it is not essential to obtain a correctly folded protein.
Indeed, all proline mutants and deleted forms displayed the same
fluorescence spectrum and exhibited similar residual activity.
Moreover, after their total activation by Der p 1, the specific
activities of the corresponding active forms were similar. Thus the
proDer p 3 propeptide does not act as an intramolecular
chaperone, as previously reported for other trypsin-like proteases
[2]. In good agreement with our findings, Craik and collaborators
[38,39] demonstrated that the recombinant expression of an active
trypsin in E. coli did not require the presence of a propeptide.
More recently, the refolding of chemically denaturated bovine
pancreatic trypsin was successfully performed without a propep-
tide [40].
The intrinsic fluorescence spectrum of Der p 3, obtained after
activation of proDer p 3 by Der p 1, was characterized by a red
shift which is also observed after maturation of trypsinogen in
trypsin. It has been attributed to increased solvent exposure of
W215 [41,42]. Similarly, W214 could be more accessible to
solvent in the mature form of the allergen Der p 3. Interestingly,
the D1–11 protein in which the 11 amino acids of the proDer p 3
propeptide are deleted was characterized by a fluorescence
spectrum and a proteolytic activity similar to the zymogen forms.
These results suggest that the addition of four to six residues, as
found at the N-terminus of the D1–11 protein, is sufficient to
maintain Der p 3 in an inactive and ‘‘zymogen-like’’ conforma-
tion. It reiterates that the neo-formed N-terminal I12 is necessary
to obtain an active conformation of Der p 3. These results can be
compared to mechanism by which trypsinogen is activated to
trypsin, in which the neo-formed N-terminal I16 forms a salt
bridge and hydrophobic interactions with D194 that trigger
formation of the so-called ‘‘activation domain’’ containing the S1
binding pocket and the oxyanion hole [43,44].
The proline residues of the propeptide do not seem to be
involved in the intrinsic thermal stability of the proenzyme.
However, because the S196A mutants exhibit significantly higher
Figure 4. Continuous enzymatic assay for proDer p 3
maturation by Der p 1. A: proDer p 3 (black) and P2A (gray), B:
P5A and C: P8A (black) and P-A (gray) mutants. Substrate hydrolysis
(10 mM IEGR-MCA) versus time curves showing the activation of
12.5 nM zymogens by Der p 1 with the indicated concentrations in
50 mM polybuffer 2 at 37uC.
doi:10.1371/journal.pone.0068014.g004
Table 4. Pseudo first order rate constants (kobs) for the
maturation of the different proDer p 3 zymogens by 11 nM
Der p 1.
Zymogen kobs (s
21)
WT proDer p 3 0.003560.0001
P2A proDer p 3 0.002960.0002
P5A proDer p 3 0.001160.0001
doi:10.1371/journal.pone.0068014.t004
Role of the Prolines of Der p 3 Propeptide
PLOS ONE | www.plosone.org 8 September 2013 | Volume 8 | Issue 9 | e68014
Role of the Prolines of Der p 3 Propeptide
PLOS ONE | www.plosone.org 9 September 2013 | Volume 8 | Issue 9 | e68014
apparent Tm (54–55uC instead of 48–49.5uC), denaturation of the
proenzyme is likely accompanied by autolysis, as observed during
the folding experiments of other proteases [40]. This phenomenon
was more observed for the P8A and P-A mutants which display a
slightly higher proteolytic activity than the other proDer p 3
zymogens.
As previously described, incubation of proDer p 3 with Der p 1
resulted in the loss of the proDer p 3 propeptide in a one-step
mechanism, which was correlated with an increase in Der p 3
activity [26]. This was followed by a decrease in activity resulting
from the autolysis of Der p 3. Under these conditions, the absence
of proline 2 did not have major consequences because the
behaviors of the P2A and D1–2 zymogens were similar to that of
proDer p 3. However, mutation of proline 5 or 8 partially or
totally impaired the maturation of proDer p 3, respectively. The
truncated form of Der p 3 (A18LAG-), which exhibits identical
apparent molecular weight to Der p 3 on SDS-PAGE analysis, was
identified after six hours activation of P8A and P-A. This form was
previously observed during the incubation of proDer p 3 with Der
p 3 and it corresponds to the auto-hydrolysis of proDer p 3 after
lysine 17 [26]. The nearly complete absence of increase of the
activity after incubation of the P8A and P-A mutants with Der p 1
is due to a lack of activation and a partial auto-hydrolysis of
zymogens. For the activation of the P5A mutant by Der p 1,
although SDS-PAGE analysis indicates that the zymogen is fully
matured, a low Der p 3 activity (25%) was observed. This is
probably due to a combination of this auto-hydrolysis phenom-
enon and a reduced activation rate of the zymogen. Indeed, the
Figure 5. Continuous mass spectrometry assay for proDer p 3 maturation by Der p 1. Electrospray mass spectra (positive ion mode) for
16 mM proDer p 3 activation by 0.16 mM Der p 1 in 25 mM ammonium acetate, pH 7.4, containing 1 mM DTT, obtained after 5 min (A) and 40 min
(B). ProD, D and prop refer to proDer p 3, Der p 3 and propeptide, respectively. C: The decrease in the proDer p 3 and the increase in the Der p 3
relative concentrations were calculated as described in the Material and Methods.
doi:10.1371/journal.pone.0068014.g005
Figure 6. Continuous mass spectrometry assays for proDer p 3 mutants maturation by Der p 1. A: P2A, B: P5A, C: P8A and D: P-A
mutants. Evolution of relative protein concentrations during the maturation of 16 mM zymogens by 0.16 mM Der p 1 in 25 mM ammonium acetate,
pH 7.4, containing 1 mM DTT. The proteins were characterized as follows: entire proDer p 3 zymogen, rDer p 3, A2ILPAS- form, S7PQAT- form,
A5ASPQA- form, A6SPQAT- form, QAT- form, AT- form, SAQAT- form and AQAT- form. Forms that are not described in Table 1 appeared during the
desalting process.
doi:10.1371/journal.pone.0068014.g006
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increase of its activation rate by using a higher concentration of
Der p 1, was sole sufficient to promote the maturation way leading
to obtaining a fully active enzyme (100%).
The quenched-flow coupled to mass spectrometry method
appeared to be useful to determine the time-course of an
enzymatic process such as proteolysis but also to compare the
catalytic efficiencies for the hydrolysis of a complex protein
sample, like for P5A, P8A and P-A mutants which contain a
mixture of species. Approximate catalytic parameters for the
activation of proDer p 3 by Der p 1 (Km of 3–6 mM and kcat/Km
of 22–44 mM21 s21) were determined with this method. Although
the P2A and P5A mutants were activated into Der p 3 during the
experiment, the maturation process of the latter was not complete.
Interestingly, the concentration of Der p 3, as measured by mass
spectrometry during the maturation process of the P5A mutant,
corresponded to the activity measured by the enzymatic matura-
tion test (25%). The P8A and P-A zymogens were not activated
during the time course of the experiment, and only truncated
forms appeared. Despite its slow maturation kinetics, the SPQAT-
protein was processed, whereas the processing of the SAQAT-
form was not detected under the conditions of the mass
spectrometry experiments.
First, these experiments indicate that prolines 5 and 8 of the
proDer p 3 propeptide are likely to be involved in the recognition
and/or presentation of the zymogen to Der p 1, with a major
contribution of proline 8. Usually, the major determinants for the
protease specificity are the P4 to P1 positions of the substrate.
Thus, proline 5, which is seven residues N-terminally located from
the cleavage site (i.e. P7 position), is likely involved in the proper
presentation of the propeptide to the cysteine protease. The
specificity profile of Der p 1 highlights its preference for a proline
at the P4 position of the substrate, which corresponds to proline 8
in the proDer p 3 propeptide [27].
Second, the activation kinetics of the deleted forms of proDer p
3 (D1–2, D1–5 and D1–8) were similar to those observed for their
proline mutant counterparts (P2A, P5A and P8A), indicating that
the amino acids surrounding the prolines and those that are N-
terminally located to proline 5 in the propeptide seem to play a
minor role in this processing.
In proteins, PRMs behave as common recognition sites for
specific interactions. Indeed, the side chains of the superficial PPII
helices are exposed to the solvent, and their structural rigidity
reduces the entropy loss upon binding [33]. Conversely, the PRM-
binding domains are often characterized by exposed aromatic side
chains that can interact with the prolines of PRMs [32]. The
P5ASP8 motif seems to be crucial for the Der p 1-proDer p 3
interaction. Interestingly, the Der p 1 protease catalytic groove is
characterized by a hydrophobic surface that contains a conserved
solvent-exposed aromatic cluster, which is likely involved in the
interactions between the PRM of proDer p 3 and Der p 1 [45,46].
Consequently, the conformation adopted by the propeptide
and, in particular, the configuration of prolines 5 and 8 could be
critical in the activation process and could determine the
activation rate of Der p 1. Notably, propeptides in which the
same proline residues are replaced by alanines or that are
significantly shortened also favor abnormal truncations that
further impair activation by Der p 1 or increase sensitivity to
autolysis after K17.
In summary, we demonstrated that the proDer p 3 propeptide
does not control the folding of proDer p 3 but is involved in the
correct processing of the enzyme. Although prolines 5 and 8 do
not greatly influence the thermal stability of the protein, these
residues protect proDer p 3 against undesired hydrolysis and play
a major role in maturation by the Der p 1 cysteine protease.
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